Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV

J Acquir Immune Defic Syndr. 2021 Sep 1;88(1):e5-e6. doi: 10.1097/QAI.0000000000002730.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-HIV Agents* / adverse effects
  • HIV Infections* / drug therapy
  • Humans
  • Pyridones / therapeutic use
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Triazoles

Substances

  • Anti-HIV Agents
  • Pyridones
  • Reverse Transcriptase Inhibitors
  • Triazoles
  • doravirine